Ethnic variation in inflammatory profile in tuberculosis
Ethnic variation in inflammatory profile in tuberculosis
Distinct phylogenetic lineages of Mycobacterium tuberculosis (MTB) cause disease in patients of particular genetic ancestry, and elicit different patterns of cytokine and chemokine secretion when cultured with human macrophages in vitro. Circulating and antigen-stimulated concentrations of these inflammatory mediators might therefore be expected to vary significantly between tuberculosis patients of different ethnic origin. Studies to characterise such variation, and to determine whether it relates to host or bacillary factors, have not been conducted. We therefore compared circulating and antigen-stimulated concentrations of 43 inflammatory mediators and 14 haematological parameters (inflammatory profile) in 45 pulmonary tuberculosis patients of African ancestry vs. 83 patients of Eurasian ancestry in London, UK, and investigated the influence of bacillary and host genotype on these profiles. Despite having similar demographic and clinical characteristics, patients of differing ancestry exhibited distinct inflammatory profiles at presentation: those of African ancestry had lower neutrophil counts, lower serum concentrations of CCL2, CCL11 and vitamin D binding protein (DBP) but higher serum CCL5 concentrations and higher antigen-stimulated IL-1 receptor antagonist and IL-12 secretion. These differences associated with ethnic variation in host DBP genotype, but not with ethnic variation in MTB strain. Ethnic differences in inflammatory profile became more marked following initiation of antimicrobial therapy, and immunological correlates of speed of elimination of MTB from the sputum differed between patients of African vs. Eurasian ancestry. Our study demonstrates a hitherto unappreciated degree of ethnic heterogeneity in inflammatory profile in tuberculosis patients that associates primarily with ethnic variation in host, rather than bacillary, genotype. Candidate immunodiagnostics and immunological biomarkers of response to antimicrobial therapy should be derived and validated in tuberculosis patients of different ethnic origin.
e1003468
Coussens, Anna K.
90e45592-5f96-4814-88fe-36ff1e879757
Wilkinson, Robert J.
efcf7079-ebfa-4270-b7a4-a578ffd91178
Nikolayevskyy, Vladyslav
40c4aad4-98f6-4f0b-a0cb-5e2c483b653b
Elkington, Paul T.
60828c7c-3d32-47c9-9fcc-6c4c54c35a15
Hanifa, Yasmeen
82a50d8c-869b-4fee-ae56-45a3b09819dd
Islam, Kamrul
1b040098-aff2-45ae-9b0d-814fbb0bf4e3
Timms, Peter M.
a5f5e81b-1e56-417e-8950-9a40f89a282e
Bothamley, Graham H.
41b779e2-ca09-4866-9007-f85c0adca690
Claxton, Alleyna P.
a155210c-14ab-4a2a-b54c-d5cdd31073e3
Packe, Geoffrey E.
050cc238-f993-47e0-a427-1c69c05513d1
Darmalingam, Mathina
43f83281-1438-49cf-8e2d-657889e9731e
Davidson, Robert N.
44078300-f1de-469d-9fb8-13f91d41c2bc
Milburn, Heather J.
002a0590-c6eb-49b3-a417-fa012d5f8fed
Baker, Lucy V.
5baa5d81-9146-4a1c-a6d0-f3c510b611b5
Barker, Richard D.
664d01bf-608d-4e09-ab10-f6c07a92131a
Young, Douglas B.
ac697be2-a9bd-441f-9edc-fa932154db81
Drobniewski, Francis A.
4b7dd9e6-79ad-4aee-b053-86d1ab697b54
Griffiths, Christopher J.
421aa6f5-153e-43f4-829e-c08a2e9984bf
Martineau, Adrian R.
066af71a-aee9-4312-ae6a-7decb7e764ef
July 2013
Coussens, Anna K.
90e45592-5f96-4814-88fe-36ff1e879757
Wilkinson, Robert J.
efcf7079-ebfa-4270-b7a4-a578ffd91178
Nikolayevskyy, Vladyslav
40c4aad4-98f6-4f0b-a0cb-5e2c483b653b
Elkington, Paul T.
60828c7c-3d32-47c9-9fcc-6c4c54c35a15
Hanifa, Yasmeen
82a50d8c-869b-4fee-ae56-45a3b09819dd
Islam, Kamrul
1b040098-aff2-45ae-9b0d-814fbb0bf4e3
Timms, Peter M.
a5f5e81b-1e56-417e-8950-9a40f89a282e
Bothamley, Graham H.
41b779e2-ca09-4866-9007-f85c0adca690
Claxton, Alleyna P.
a155210c-14ab-4a2a-b54c-d5cdd31073e3
Packe, Geoffrey E.
050cc238-f993-47e0-a427-1c69c05513d1
Darmalingam, Mathina
43f83281-1438-49cf-8e2d-657889e9731e
Davidson, Robert N.
44078300-f1de-469d-9fb8-13f91d41c2bc
Milburn, Heather J.
002a0590-c6eb-49b3-a417-fa012d5f8fed
Baker, Lucy V.
5baa5d81-9146-4a1c-a6d0-f3c510b611b5
Barker, Richard D.
664d01bf-608d-4e09-ab10-f6c07a92131a
Young, Douglas B.
ac697be2-a9bd-441f-9edc-fa932154db81
Drobniewski, Francis A.
4b7dd9e6-79ad-4aee-b053-86d1ab697b54
Griffiths, Christopher J.
421aa6f5-153e-43f4-829e-c08a2e9984bf
Martineau, Adrian R.
066af71a-aee9-4312-ae6a-7decb7e764ef
Coussens, Anna K., Wilkinson, Robert J., Nikolayevskyy, Vladyslav, Elkington, Paul T., Hanifa, Yasmeen, Islam, Kamrul, Timms, Peter M., Bothamley, Graham H., Claxton, Alleyna P., Packe, Geoffrey E., Darmalingam, Mathina, Davidson, Robert N., Milburn, Heather J., Baker, Lucy V., Barker, Richard D., Young, Douglas B., Drobniewski, Francis A., Griffiths, Christopher J. and Martineau, Adrian R.
(2013)
Ethnic variation in inflammatory profile in tuberculosis.
PLOS Pathogens, 9 (7), .
(doi:10.1371/journal.ppat.1003468).
(PMID:23853590)
Abstract
Distinct phylogenetic lineages of Mycobacterium tuberculosis (MTB) cause disease in patients of particular genetic ancestry, and elicit different patterns of cytokine and chemokine secretion when cultured with human macrophages in vitro. Circulating and antigen-stimulated concentrations of these inflammatory mediators might therefore be expected to vary significantly between tuberculosis patients of different ethnic origin. Studies to characterise such variation, and to determine whether it relates to host or bacillary factors, have not been conducted. We therefore compared circulating and antigen-stimulated concentrations of 43 inflammatory mediators and 14 haematological parameters (inflammatory profile) in 45 pulmonary tuberculosis patients of African ancestry vs. 83 patients of Eurasian ancestry in London, UK, and investigated the influence of bacillary and host genotype on these profiles. Despite having similar demographic and clinical characteristics, patients of differing ancestry exhibited distinct inflammatory profiles at presentation: those of African ancestry had lower neutrophil counts, lower serum concentrations of CCL2, CCL11 and vitamin D binding protein (DBP) but higher serum CCL5 concentrations and higher antigen-stimulated IL-1 receptor antagonist and IL-12 secretion. These differences associated with ethnic variation in host DBP genotype, but not with ethnic variation in MTB strain. Ethnic differences in inflammatory profile became more marked following initiation of antimicrobial therapy, and immunological correlates of speed of elimination of MTB from the sputum differed between patients of African vs. Eurasian ancestry. Our study demonstrates a hitherto unappreciated degree of ethnic heterogeneity in inflammatory profile in tuberculosis patients that associates primarily with ethnic variation in host, rather than bacillary, genotype. Candidate immunodiagnostics and immunological biomarkers of response to antimicrobial therapy should be derived and validated in tuberculosis patients of different ethnic origin.
Other
fetchObject.action_uri=info_doi%2F10.1371%2Fjournal.ppat.1003468&representation=PDF
- Version of Record
Available under License Other.
More information
Published date: July 2013
Additional Information:
AUTHOR SUMMARY: Mycobacterium tuberculosis (MTB) is the causative agent of tuberculosis. Genetically distinct strains of MTB cause disease in particular ethnic groups, and these strains vary in their ability to elicit inflammatory responses from antigen-presenting cells in vitro. Circulating and antigen-stimulated concentrations of inflammatory mediators (‘inflammatory profile’) might therefore be expected to differ between tuberculosis patients of different ethnic origin; however, this question has not previously been addressed. We therefore conducted a study to characterise ethnic variation in inflammatory profiles in a cohort of 128 newly-diagnosed tuberculosis patients in London, UK. Patients of African vs. Eurasian ancestry had distinct inflammatory profiles at presentation; differences did not relate to MTB strain variation between groups, but they did associate with ethnic variation in host genotype. Moreover, immunological correlates of the rate of MTB clearance from sputum differed between patients of African vs. Eurasian ancestry. Our findings provide insight into the mechanisms underlying ethnic variation in inflammatory profile in tuberculosis patients, and indicate that candidate immunodiagnostics and immunological biomarkers of response to tuberculosis therapy should be derived and validated in tuberculosis patients of different ethnic origin.
Organisations:
Clinical & Experimental Sciences
Identifiers
Local EPrints ID: 355594
URI: http://eprints.soton.ac.uk/id/eprint/355594
ISSN: 1553-7366
PURE UUID: b071b514-b2c3-43e7-a905-41fbbf55acb3
Catalogue record
Date deposited: 02 Sep 2013 16:05
Last modified: 15 Mar 2024 03:43
Export record
Altmetrics
Contributors
Author:
Anna K. Coussens
Author:
Robert J. Wilkinson
Author:
Vladyslav Nikolayevskyy
Author:
Yasmeen Hanifa
Author:
Kamrul Islam
Author:
Peter M. Timms
Author:
Graham H. Bothamley
Author:
Alleyna P. Claxton
Author:
Geoffrey E. Packe
Author:
Mathina Darmalingam
Author:
Robert N. Davidson
Author:
Heather J. Milburn
Author:
Lucy V. Baker
Author:
Richard D. Barker
Author:
Douglas B. Young
Author:
Francis A. Drobniewski
Author:
Christopher J. Griffiths
Author:
Adrian R. Martineau
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
